Balyasny Asset Management LLC Biogen Inc. Put Options Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$189.07 - $236.8 $1.21 Million - $1.52 Million
6,400 New
6,400 $1.24 Million
Q2 2020

Aug 14, 2020
SELL
$258.66 - $342.55 $23.3 Million - $30.8 Million
-90,000 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$268.85 - $341.04 $8.87 Million - $11.3 Million
33,000 Added 57.89%
90,000 $28.5 Million
Q3 2018

Nov 14, 2018
BUY
$293.51 - $383.83 $16.7 Million - $21.9 Million
57,000 New
57,000 $19.3 Million

Others Institutions Holding BIIB

# of Institutions
1,038
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email